We are very pleased to share our 2023 #AnnualReport – Future Ready. We hope you will read it and share it. You can find it on our website: https://lnkd.in/gE8_Cxf Peruse the pages to read about our partnerships, projects, portfolio companies, people (like our terrific Board of Directors) and progress. Shoutouts (and thanks!): Networks of Centres of Excellence, Government of Canada, OmniaBio, McMaster Innovation Park, CCRM Nordic, CCRM Australia, Canadian Advanced Therapies Training Institute, University of Toronto, Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc., Jim Wilson, Peter Zandstra, McMaster University, Mohawk College, Catamaran Bio, Ontario Veterinary College, University of Guelph, The University of Queensland, Multiplex, Visions of Science , Vinnova, GoCo Health Innovation City, Glenn MacLean, Sarah Lepage, Medicine by Design - University of Toronto, Stem Cell Network and more!!!
CCRM
Biotechnology Research
Toronto, Ontario 22,980 followers
Commercializing Living Therapies
About us
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.
- Website
-
http://www.ccrm.ca
External link for CCRM
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Toronto, Ontario
- Type
- Nonprofit
- Founded
- 2011
- Specialties
- Commercialization, Cell Reprogramming, Cell Manufacturing, Biomaterials Tissue Mimetics, Integration of Science Business, Industry Consortium, and Contract Services
Locations
-
Primary
Get directions
MaRS Centre, West Tower
661 University Ave., Suite 1002
Toronto, Ontario M5G 1M1, CA
-
Get directions
Employees at CCRM
-
Sherif Sheta
CIO in Cell & Gene Therapy - CCRM | OmniaBio
-
Louis Rogers PhD PMP DTM
-
Phil Vanek
Chief Technology Officer at Gamma Biosciences
-
Valorie Tutt
Legal and Regulatory Leader within both Private and Public Sector | Negotiator | Governance | Policy | Business Partner | Healthcare | Procurement…
Updates
-
Great progress by the team at CCRM Nordic. Congratulations everyone!
🚀 𝐐3 𝐔𝐩𝐝𝐚𝐭𝐞🚀 We are thrilled to share some exciting progress and achievements from the past quarter: · 𝐅𝐚𝐜𝐢𝐥𝐢𝐭𝐲 𝐋𝐚𝐲𝐨𝐮𝐭 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬: We are making significant strides in finalizing our GMP facility layout. 🤫 Parts of the floor plan have been finalized, bringing us closer to our goal of a 𝒔𝒕𝒂𝒕𝒆-𝒐𝒇-𝒕𝒉𝒆-𝒂𝒓𝒕 𝒇𝒂𝒄𝒊𝒍𝒊𝒕𝒚. · 𝐓𝐞𝐚𝐦 𝐆𝐫𝐨𝐰𝐭𝐡: Our #team continues to grow and thrive! Since Q2, we’ve welcomed several talented individuals who are already making a positive impact. A big shoutout to our new employees Chao Sheng, Pedro Velica and Amina Agović and consultants Anna Rahmqvist and Patrik Heimby for joining us on this journey. · 𝐍𝐞𝐰 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞: We are officially in business! We have successfully taken on our first project, marking a significant #milestone for our services. 🙌 Thank you to everyone who has supported us along the way. We look forward to sharing more updates as we continue to grow and achieve our goals. #CCRMNordic #TeamGrowth #GMP #biotechnology #biotech Teamtastic: Chao Sheng, Pedro Velica, Simon Ravau, Sarah Callens, Jim Lund, Nancy Kirjavainen, Anders Larsson, Anna Falk, Amina Agović, Kerstin Dahlenborg, Anders Aspegren, Fredrik Wessberg, Juliana Kovacka, Helena Choukair, Stephanie Mattsson, Anna Rahmqvist, Stephanie Mattsson, Catherine Concaro, Karina Lövstedt, Arvind M Padma and Samuel Alsen
-
CCRM reposted this
More golden insights from Sven Kili 👇 How should the European side of the industry be considered in order to facilitate a progressive mindset? "Not as a mini-US..." Catch up on the hottest topics from the Advanced Therapies Europe meeting in this short round-up. #ATE24 #CellTherapy #GeneTherapy
🇪🇺 "The important thing to remember is, Europe is not America [...] it is not a mini-US." 📹 In this second IBTV interview from Phacilitate's Advanced Therapies Europe, Sven Kili shares his thoughts on this year's meeting in Lisbon, including his thoughts on the European landscape for advanced therapies, key messages and lessons learned from discussions at the event. ▶ Watch more from Sven amongst other KOLs from the show floor, here: https://lnkd.in/gk_6puWV #AdvancedTherapies #CellTherapy #GeneTherapy #Reimbursement #ATE24
-
Medicine by Design - University of Toronto and The CCRM Foundation are pleased to announce that The CCRM Foundation will be the top event sponsor at the 9th Annual Medicine by Design Symposium, taking place December 9, 2024, at MaRS Discovery District. Michael May, Chair of The CCRM Foundation Board, says: “We’re thrilled to be introducing The CCRM Foundation to the regenerative medicine community in Toronto through our support of the Medicine by Design symposium. This sponsorship is an important way to support and engage Toronto’s world-leading research community. The CCRM Foundation is leveraging the sustainability, track record and expertise of [CCRM and] global ecosystem partners to raise new funding that will be deployed back into high-impact initiatives, including Medicine by Design.” Read the release here: https://lnkd.in/gU_MXHbR Learn more about #TheCCRMFoundation here: https://lnkd.in/diBAhEs9
-
-
If you're a grad student, this blog is for you! PhD candidate and blogger Francesco Zangari shares how he uses #ChatGPT to save time and assist him in different areas of his research. https://lnkd.in/gTP6V6Ad Interested in more on the topic of #AI? Francesco links to blog posts by Laine B. and Meighan Atkinson.
-
For the second time now, we have had an educational and thought-provoking presentation from Dr. Matthew Wildcat, Assistant Professor of Political Science and Native Studies at the University of Alberta (U of A). In recognition of the National Day for Truth and Reconciliation, Dr. Wildcat described Indigenous relationality, explaining the concept through story-telling and memorable examples. He also spoke about the Truth and Reconciliation Commission report and answered questions from our team. If you would like to learn more about Indigenous Canada, U of A offers a free, online course. https://lnkd.in/g6KVsGqp
Indigenous Canada
ualberta.ca
-
Congratulations to Peter Zandstra, co-founder and Chief Scientific Officer at CCRM, for receiving the 2024 BIOTECanada Gold Leaf Award for Leadership. This award recognizes the important contributions that Dr. Zandstra has made to the advancement of stem cell bioengineering and regenerative medicine through his academic excellence, his role at CCRM, and as Founding Director of the School of Biomedical Engineering at UBC and Director of the Michael Smith Laboratories. Dr. Zandstra is also recognized for building companies such as Notch Therapeutics and ExCellThera Inc. The award was presented to Dr. Zandstra at the BIOTECanada BIONATION 2024 conference earlier this week in Ottawa, Ontario. Please join us in congratulating Peter. (Pictured L-R: Oliver Technow, BIOVECTRA & Chair of BIOTECanada, Peter Zandstra, and Andrew Casey, BIOTECanada)
-
-
CCRM reposted this
With the Alliance for Regenerative Medicine’s 2024 Cell & Gene Meeting on the Mesa around the corner, I’m gearing up for an unforgettable experience in Phoenix, AZ. I look forward to engaging with industry leaders and innovators to tackle some of the biggest challenges in #CellandGeneTherapy, including enhancing affordability and access. Let’s connect during the event to discuss how CCRM can help accelerate your technology and drive therapeutic success. #CGMesa24 #CellandGeneTherapy #CellTherapy #GeneTherapy
-
-
CCRM reposted this
Deadline extended! Submit an abstract for the #MbDSymposium poster competition! This is a great opportunity for trainees to connect with the MbD community and share exciting results from their projects. Submit by Oct 18: https://lnkd.in/gXA-Ns7G
-
-
In case you missed this exciting news for Canadian patients: Health Canada has granted marketing authorization for CASGEVY®, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia. https://lnkd.in/eCXTF99d Coincidentally, Signals blogger Anis Fahandej-Sadi just wrote about thalassemia. Read it here: https://lnkd.in/g-YhSRUf
Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
newswire.ca